GSK3B and dementia: The present findings appear consistent with other research which found a decrease in hippocampal mRNA expression of β1‐Catenin (Bahlakeh et al., 2022), PSD‐95 (Shao et al., 2011), IGF‐1 (Gong et al., 2012), and TGF‐β1 (Caraci et al., 2012) as well as an increase in expression of GSK‐3β (Gomez‐Sintes et al., 2011), and NR2B (Liu et al., 2012) following dementia models.